Scientific Library of Tomsk State University

   E-catalog        

Normal view MARC view

Пилотное исследование острой токсичности ингибитора Tdp1 Е. О. Казакова

By: Казакова, Елена ОлеговнаMaterial type: ArticleArticleOther title: Pilot study of acute toxicity of Tdp1 inhibitor [Parallel title]Subject(s): рак легкого | ингибиторы | злокачественные новообразования | ферменты | репарацииGenre/Form: статьи в сборниках Online resources: Click here to access online In: Перспективы развития фундаментальных наук. Т. 4 : сборник научных трудов XV Международной конференции студентов, аспирантов и молодых ученых, 24-27 апреля 2018 г Т. 4 : Биология и фундаментальная медицина. С. 63-65Abstract: To date, malignant neoplasms are the most pressing medical and social problem both in our country and abroad, despite the introduction of innovative technologies in diagnostics, therapy, and prophylactics. Lung cancer is the most common malignant neoplasm worldwide. Since the beginning of the twentieth century, the incidence of lung cancer has increased, and its growth is especially pronounced in industrially developed countries, where it ranks first in the structure of cancer morbidity. In Russia, over the last ten years, the incidence of lung cancer has decreased, but yet more than 1000000 new cases are diagnosed annually, and lung cancer by remains in first place among all malignant neoplasms among men. Tyrosyl-DNA Phosphodiesterase 1 (Tdpl) that result in stalled Topi are commonly employed against cancer. Nowadays, major methods are used for the treatment of patients with lung cancer: surgery, radiation, chemoradiation, drugs, and combined methods. Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Библиогр.: 4 назв.

To date, malignant neoplasms are the most pressing medical and social problem both in our country and abroad, despite the introduction of innovative technologies in diagnostics, therapy, and prophylactics. Lung cancer is the most common malignant neoplasm worldwide. Since the beginning of the twentieth century, the incidence of lung cancer has increased, and its growth is especially pronounced in industrially developed countries, where it ranks first in the structure of cancer morbidity. In Russia, over the last ten years, the incidence of lung cancer has decreased, but yet more than 1000000 new cases are diagnosed annually, and lung cancer by remains in first place among all malignant neoplasms among men. Tyrosyl-DNA Phosphodiesterase 1 (Tdpl) that result in stalled Topi are commonly employed against cancer. Nowadays, major methods are used for the treatment of patients with lung cancer: surgery, radiation, chemoradiation, drugs, and combined methods. Combination chemotherapy with DNA repair inhibitors can potentially improve response to these widely used chemotherapeutics.

There are no comments on this title.

to post a comment.
Share